KMT2A and leukemia: In addition, although high methylation of the ABCB1 promoter in MLL+ children inhibits its mRNA expression (42), decitabine can restore ABCB1 expression through demethylation and enhance the sensitivity of leukemia cells to chemotherapy drugs (decreased IC50) (43).